{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T08:06:55Z","timestamp":1768291615570,"version":"3.49.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T00:00:00Z","timestamp":1651449600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T00:00:00Z","timestamp":1651449600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1038\/s41390-022-02061-4","type":"journal-article","created":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T19:02:46Z","timestamp":1651518166000},"page":"89-96","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Immunomodulatory therapy using a pediatric dialysis system ameliorates septic shock in miniature pigs"],"prefix":"10.1038","volume":"93","author":[{"given":"Kimberly A.","family":"Johnston","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher J.","family":"Pino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Goldia","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Skylar K.","family":"Ketteler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuart L.","family":"Goldstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. David","family":"Humes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,5,2]]},"reference":[{"key":"2061_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1611391","volume":"376","author":"A Kaddourah","year":"2017","unstructured":"Kaddourah, A., Basu, R. K., Bagshaw, S. M., Goldstein, S. L. & AWARE Investigators. Epidemiology of acute kidney injury in critically ill children and young adults. N. Engl. J. Med. 376, 11\u201320 (2017).","journal-title":"N. Engl. J. Med."},{"key":"2061_CR2","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/j.1525-139X.2011.00834.x","volume":"24","author":"SL Goldstein","year":"2011","unstructured":"Goldstein, S. L. Advances in pediatric renal replacement therapy for acute kidney injury. Semin. Dial. 24, 187\u2013191 (2011).","journal-title":"Semin. Dial."},{"key":"2061_CR3","doi-asserted-by":"publisher","first-page":"732","DOI":"10.2215\/CJN.03200906","volume":"2","author":"JM Symons","year":"2007","unstructured":"Symons, J. M. et al. Demographic characteristics of pediatric continuous renal replacement therapy: a report of the prospective pediatric continuous renal replacement therapy registry. Clin. J. Am. Soc. Nephrol. 2, 732\u2013738 (2007).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"2061_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/cc10554","volume":"15","author":"RK Basu","year":"2011","unstructured":"Basu, R. K. et al. Identification of candidate serum biomarkers for severe septic shock-associated kidney injury via microarray. Crit. Care 15, R273 (2011).","journal-title":"Crit. Care"},{"key":"2061_CR5","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1056\/NEJMra021333","volume":"348","author":"RS Hotchkiss","year":"2003","unstructured":"Hotchkiss, R. S. & Karl, I. E. The pathophysiology and treatment of sepsis. N. Engl. J. Med. 348, 138\u2013150 (2003).","journal-title":"N. Engl. J. Med."},{"key":"2061_CR6","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1189\/jlb.0607373","volume":"83","author":"M Schouten","year":"2008","unstructured":"Schouten, M., Wiersinga, W. J., Levi, M. & van der Poll, T. Inflammation, endothelium, and coagulation in sepsis. J. Leukoc. Biol. 83, 536\u2013545 (2008).","journal-title":"J. Leukoc. Biol."},{"key":"2061_CR7","doi-asserted-by":"crossref","unstructured":"Humes, H. D., Fissell, W. H. & Weitzel, W. F. The bioartificial kidney in the treatment of acute renal failure. Kidney Int. 61, S121\u2013S125 (2002).","DOI":"10.1046\/j.1523-1755.61.s80.22.x"},{"key":"2061_CR8","first-page":"71","volume":"20","author":"HD Humes","year":"2000","unstructured":"Humes, H. D. Bioartificial kidney for full renal replacement therapy. Semin. Nephrol. 20, 71\u201382 (2000).","journal-title":"Semin. Nephrol."},{"key":"2061_CR9","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0140-6736(06)69005-3","volume":"368","author":"KA Brown","year":"2006","unstructured":"Brown, K. A. et al. Neutrophils in development of multiple organ failure in sepsis. Lancet 368, 157\u2013169 (2006).","journal-title":"Lancet"},{"key":"2061_CR10","doi-asserted-by":"publisher","first-page":"e18584","DOI":"10.1371\/journal.pone.0018584","volume":"6","author":"F Ding","year":"2011","unstructured":"Ding, F. et al. A biomimetic membrane device that modulates the excessive inflammatory response to sepsis. PLoS ONE 6, e18584 (2011).","journal-title":"PLoS ONE"},{"key":"2061_CR11","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1111\/sdi.12032","volume":"26","author":"JA Tumlin","year":"2013","unstructured":"Tumlin, J. A. et al. The effect of the selective cytopheretic device on acute kidney injury outcomes in the intensive care unit: a multicenter pilot study. Semin. Dial. 26, 616\u2013623 (2013).","journal-title":"Semin. Dial."},{"key":"2061_CR12","doi-asserted-by":"publisher","first-page":"e0132482","DOI":"10.1371\/journal.pone.0132482","volume":"10","author":"JA Tumlin","year":"2015","unstructured":"Tumlin, J. A. et al. A multi-center, randomized, controlled, pivotal study to assess the safety and efficacy of a selective cytopheretic device in patients with acute kidney injury. PLoS ONE 10, e0132482 (2015).","journal-title":"PLoS ONE"},{"key":"2061_CR13","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.ekir.2020.12.010","volume":"6","author":"SL Goldstein","year":"2021","unstructured":"Goldstein, S. L. et al. Use of the selective cytopheretic device in critically ill children. Kidney Int. Rep. 6, 775\u2013784 (2021).","journal-title":"Kidney Int. Rep."},{"key":"2061_CR14","doi-asserted-by":"crossref","unstructured":"Selewski, D. T. et al. Immunomodulatory device therapy in a pediatric patient with acute kidney injury and multiorgan dysfunction. Kidney Int. Rep. 2, 1259\u20131264 (2017).","DOI":"10.1016\/j.ekir.2017.06.131"},{"key":"2061_CR15","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.ekir.2017.12.012","volume":"3","author":"CJ Pino","year":"2018","unstructured":"Pino, C. J., Westover, A. J., Johnston, K. A., Buffington, D. A. & Humes, H. D. Regenerative medicine and immunomodulatory therapy: insights from the kidney, heart, brain, and lung. Kidney Int. Rep. 3, 771\u2013783 (2018).","journal-title":"Kidney Int. Rep."},{"key":"2061_CR16","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1093\/ndt\/gfs503","volume":"28","author":"CJ Pino","year":"2013","unstructured":"Pino, C. J. et al. Cell-based approaches for the treatment of systemic inflammation. Nephrol. Dial. Transpl. 28, 296\u2013302 (2013).","journal-title":"Nephrol. Dial. Transpl."},{"key":"2061_CR17","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1159\/000341649","volume":"34","author":"CJ Pino","year":"2012","unstructured":"Pino, C. J., Yevzlin, A. S., Tumlin, J. & Humes, H. D. Cell-based strategies for the treatment of kidney dysfunction: a review. Blood Purif. 34, 117\u2013123 (2012).","journal-title":"Blood Purif."},{"key":"2061_CR18","doi-asserted-by":"crossref","unstructured":"Goldstein, S. L. et al. Survival of infants treated with ckrt: comparing adapted adult platforms with the carpediem. Pediatr. Nephrol. 37, 667\u2013675 (2021).","DOI":"10.1007\/s00467-021-05180-y"},{"key":"2061_CR19","unstructured":"National Research Council. Guide for the Care and Use of Laboratory Animals: Eighth Edition (The National Academies Press, 2011)."},{"key":"2061_CR20","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1177\/0300985811402846","volume":"49","author":"MM Swindle","year":"2012","unstructured":"Swindle, M. M., Makin, A., Herron, A. J., Clubb, F. J. Jr. & Frazier, K. S. Swine as models in biomedical research and toxicology testing. Vet. Pathol. 49, 344\u2013356 (2012).","journal-title":"Vet. Pathol."},{"key":"2061_CR21","unstructured":"Waterhouse, A. et al. Modified clinical monitoring assessment criteria for multi-organ failure during bacteremia and sepsis progression in a pig model. Adv. Crit. Care Med. 1, 002 (2018)."},{"key":"2061_CR22","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/s12882-021-02443-6","volume":"22","author":"L Yessayan","year":"2021","unstructured":"Yessayan, L. et al. Regional citrate anticoagulation \u201cnon-shock\u201d protocol with pre-calculated flow settings for patients with at least 6 l\/hour liver citrate clearance. BMC Nephrol. 22, 244 (2021).","journal-title":"BMC Nephrol."},{"key":"2061_CR23","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S0165-2427(01)00286-0","volume":"80","author":"J Dominguez","year":"2001","unstructured":"Dominguez, J. et al. Workshop studies on monoclonal antibodies in the myeloid panel with Cd11 specificity. Vet. Immunol. Immunopathol. 80, 111\u2013119 (2001).","journal-title":"Vet. Immunol. Immunopathol."},{"key":"2061_CR24","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1001\/jama.2020.18618","volume":"324","author":"A Zarbock","year":"2020","unstructured":"Zarbock, A. et al. Effect of regional citrate anticoagulation vs systemic heparin anticoagulation during continuous kidney replacement therapy on dialysis filter life span and mortality among critically ill patients with acute kidney injury: a randomized clinical trial. JAMA 324, 1629\u20131639 (2020).","journal-title":"JAMA"}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-022-02061-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-022-02061-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-022-02061-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T18:06:03Z","timestamp":1674669963000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-022-02061-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,2]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["2061"],"URL":"https:\/\/doi.org\/10.1038\/s41390-022-02061-4","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,2]]},"assertion":[{"value":"4 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"K.A.J., C.J.P., S.K.K., and H.D.H. are employees of Innovative BioTherapies (IBT). H.D.H. is a shareholder, an officer, and a director of IBT. K.A.J., C.J.P., and H.D.H. are shareholders of SeaStar Medical, Inc. C.J.P. and H.D.H. are inventors on patents held by SeaStar Medical. H.D.H. is a scientific advisor, a director, and a consultant to SeaStar Medical. S.L.G. receives consulting fees from SeaStar Medical.\u00a0G.C. has no competing interests. SeaStar Medical was not involved in the execution of this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"No patient consent was required for this pre-clinical research study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}